Faecal incontinence is a serious public health problem, affecting over 67 million people in Europe. AMELIE is primarily concerned with the effect of injury to the anal sphincter by childbirth, surgery or trauma. Many such patients are unsuitable for current surgical options. Our research aims to provide a new form of regenerative treatment, as explained in this short video...
The AMELIE consortium is made up of 13 partners from across Europe, including the UK, Portugal, Spain, France, Germany, Italy, Austria, Denmark and the Netherlands. Organisations include universities, hospitals, research institutes, consultants and charities. The project will be coordinated by University College London, however a different organisation will lead on each work package...
We seek to manufacture and deliver anchorage-dependent to establish more effective regenerative therapies for faecal incontinence.